Press Release Lilly calls on online platforms, payment companies and regulators to shut down the illegal retatrutide black market 3 hours ago
Press Release Lilly reports second-quarter 2026 financial results, raises full-year guidance, and highlights continued growth and pipeline progress Aug 5
Press Release Lilly’s olomorasib receives U.S. FDA’s Breakthrough Therapy designation for the treatment of previously treated KRAS G12C-mutant advanced pancreatic cancer Aug 3
Press Release Lilly confirms date and conference call for second-quarter 2026 financial results announcement Jul 22